ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,308.15
1.17%
Dow Jones
39,908.00
0.00%
US Dollar vs MXN
16.73051
0.28%
Brent Oil
82.665
0.01%
Bitcoin
66,365.13
0.16%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. EyePoint Pharmaceuticals Inc (EYPT)

  7. EyePoint Pharmaceuticals Inc (EYPT) Noticias

EYPT EyePoint Pharmaceuticals Inc

12.94
0.00 (0.00%)
Pre Mercado
Última actualización: 07:02:51
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
EyePoint Pharmaceuticals Inc EYPT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 12.94 07:02:51
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
12.94
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
16/5/202406:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
09/5/202409:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202415:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202406:05EDGAR2Form 8-K - Current report
08/5/202406:00GLOBEEyePoint Pharmaceuticals Reports First Quarter 2024..
06/5/202408:25EDGAR2Form 8-K - Current report
06/5/202406:00GLOBEEyePoint Pharmaceuticals Announces Topline Data from the..
16/4/202406:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
02/4/202406:00GLOBEEyePoint Pharmaceuticals Expands Scientific Advisory Board..
18/3/202406:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
08/3/202412:53EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202406:05EDGAR2Form 8-K - Current report
07/3/202406:00GLOBEEyePoint Pharmaceuticals Reports Fourth Quarter and..
04/3/202416:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202416:37EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/3/202406:01EDGAR2Form 8-K - Current report
04/3/202406:00GLOBEEyePoint Pharmaceuticals Announces Appointment of Ramiro..
29/2/202406:00GLOBEEyePoint Pharmaceuticals to Report Fourth Quarter and..
27/2/202406:00GLOBEEyePoint Pharmaceuticals Announces Participation at Upcoming..
22/2/202416:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202406:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
14/2/202420:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202416:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202416:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202416:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202416:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202416:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202411:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/2/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202415:20GLOBEEyePoint Pharmaceuticals Announces Two Presentations of..
02/2/202415:22EDGAR2Form 144 - Report of proposed sale of securities
31/1/202406:00GLOBEEyePoint Pharmaceuticals to Present at the Guggenheim..
30/1/202415:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202416:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202416:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202416:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202417:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202417:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202415:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202415:25EDGAR2Form 144 - Report of proposed sale of securities
24/1/202415:17EDGAR2Form 144 - Report of proposed sale of securities
23/1/202415:42EDGAR2Form 144 - Report of proposed sale of securities
23/1/202415:19EDGAR2Form 144 - Report of proposed sale of securities
22/1/202415:19EDGAR2Form 144 - Report of proposed sale of securities
16/1/202417:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202417:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202406:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
11/1/202416:33EDGAR2Form 144 - Report of proposed sale of securities
11/1/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202415:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
EYPT
EyePoint Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados